💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Swiss drugmaker Roche says to shutter Rio de Janeiro plant

Published 03/26/2019, 07:27 PM
Updated 03/26/2019, 07:30 PM
© Reuters. FILE PHOTO: Roche tablets are seen positioned in front of a displayed Roche logo in this photo illustration shot in Zenica

(Reuters) - Swiss drugmaker Roche will close its manufacturing plant in the Brazilian city of Rio de Janeiro, shuttering operations over the next five years before selling the plot, the company said in a statement on Tuesday.

Located in the neighborhood of Jacarepagua, the plant makes products for Latin America and Europe, and currently employees 440 Roche workers and around 200 contractors, the company said.

"In light of the evolving product portfolio and future lower production volumes, Roche took the difficult decision to plan the phase-out of operations at the manufacturing site in Rio de Janeiro," the company said.

"Employees on site will receive the best possible support during the coming years, while Roche stays committed to reliably supply high-quality products to patients until closure of the site."

© Reuters. FILE PHOTO: Roche tablets are seen positioned in front of a displayed Roche logo in this photo illustration shot in Zenica

It added that it would continue to operate in Brazil at its two plants in Sao Paulo and Goias states.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.